What will be the approximate SUV value within the stomach on attenuation corrected images after consuming non-flavored, glucose-free oral contrast?

What will be the approximate SUV value within the stomach on attenuation corrected images after consuming non-flavored, glucose-free oral contrast?

• A. Approaching 0
• B. Less than 1
• C. About 2
• D. Greater than 3

Answer: (D)

In the context of PET imaging, the Standardized Uptake Value (SUV) is a measure that reflects the concentration of radiotracer uptake in a region of interest relative to a standardized reference. After the consumption of non-flavored, glucose-free oral contrast, the SUV value within the stomach is expected to be relatively low, primarily due to the absence of glucose, which does not stimulate increased uptake of the radiotracer in gastric cells or surrounding tissue. Typically, the consumption of glucose-free contrast would not lead to elevated SUV values because there is no metabolic drive to enhance FDG uptake as there would be with glucose-containing substances. While the SUV can vary based on several factors, including the timing of imaging post-consumption and the specific characteristics of the contrast used, values approaching zero or less than 1 would be more likely in this scenario. The SUV value exceeding 3 would typically indicate a much higher level of metabolic activity, commonly associated with pathological processes such as malignancy, which would not apply in this case where the oral contrast is non-glucose and non-flavored. Thus, an SUV greater than 3 would not be expected in the stomach under these conditions.

In the context of PET imaging, the Standardized Uptake Value (SUV) is a measure that reflects the concentration of radiotracer uptake in a region of interest relative to a standardized reference. After the consumption of non-flavored, glucose-free oral contrast, the SUV value within the stomach is expected to be relatively low, primarily due to the absence of glucose, which does not stimulate increased uptake of the radiotracer in gastric cells or surrounding tissue.

Typically, the consumption of glucose-free contrast would not lead to elevated SUV values because there is no metabolic drive to enhance FDG uptake as there would be with glucose-containing substances. While the SUV can vary based on several factors, including the timing of imaging post-consumption and the specific characteristics of the contrast used, values approaching zero or less than 1 would be more likely in this scenario.

The SUV value exceeding 3 would typically indicate a much higher level of metabolic activity, commonly associated with pathological processes such as malignancy, which would not apply in this case where the oral contrast is non-glucose and non-flavored. Thus, an SUV greater than 3 would not be expected in the stomach under these conditions.